Capricor Therapeutics Inc (CAPR)

[dia76ca]

Capricor highlights for newbies...
* Fewer than 50 million shares outstanding.
* No debt.
* Holds around $99 million cash.
* $1.5 Billion milestones expected in US, Japan and Europe.
* European partnership coming (NS or BP?).
* $150+ million PRV voucher.
* 35-50 % royalty rate.
* Long term data shows Deramiocel is SAFE !
* 4 year DMD OLE data shows heart near stabilization and dramatic slowing in decline of upper body muscle strength.
* Phase 3 data confirms very strong LVEF and PUL data !
* Becker (Orphan Drug) and other cardiomyopathies are the next targets.
* NIAID funded StealthX exosome vaccine trial reports in early 2026. Going "very,very well".
* Cash rich with several StealthX exosome targets ready to partner (timing?).
* Greatly undervalued. Wainwright set $77 target over a year ago! And Big Pharma will be interested in deramiocel for cardiomyopathy ,and the entire StealthX platform .